Osteoclasts generate cross-linked collagen N-telopeptides (NTx) but not free pyridinolines when cultured on human bone

Bone

Volumn 21, Issue 2, 1997, Pages 129-136

  Apone, S ^a   Lee, M Y ^b   Eyre, D R ^b  

^a Ostex International Inc   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Bone resorption; Collagen cross links; Osteoclasts; Pyridinolines; Telopeptides

Indexed keywords

ACID PHOSPHATASE; ALENDRONIC ACID; AMINO TERMINAL TELOPEPTIDE; CALCITONIN; CALCITRIOL; COLLAGEN; COLLAGEN TYPE 1; HYDROCORTISONE; PEPTIDE; PYRIDINOLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW CULTURE; CELL CULTURE; CELL STIMULATION; COLLAGEN DEGRADATION; CONTROLLED STUDY; CROSS LINKING; CULTURE MEDIUM; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOREACTIVITY; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; URINARY EXCRETION;

ACID PHOSPHATASE; ALENDRONATE; AMINO ACIDS; ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; BONE MARROW; BONE RESORPTION; CALCITONIN; CALCITRIOL; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLLAGEN; COLLAGEN TYPE I; CULTURE MEDIA; DENTIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMUR; HUMANS; HYDROCORTISONE; ISOENZYMES; MICE; MICE, INBRED BALB C; OSTEOCLASTS; PEPTIDE BIOSYNTHESIS; PEPTIDES; RECEPTORS, CALCITONIN;

EID: 0030772533     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(97)00105-1     Document Type: Article

References (44)

1. Beardsworth, L. J., Eyre, D. R., and Dickson, I. R. Changes with age in the urinary excretion of lysyl- and hydroxylysylpyridinoline, two new markers of bone collagen turnover. J Bone Miner Res 5:671-676; 1990.
2. Bell, N. H., Hollis, B. W., Shary, J. R., Eyre, D. R., Eastell, R., Colwell, A., and Russell, R. G. Diclofenac sodium inhibits bone resorption in postmenopausal women. Am J Med 96:349-353; 1994.
3. Black, D., Duncan, A., and Robins, S. P. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reverse-phase high-performance liquid chromatography. Anal Biochem 169:197-203; 1988.
4. Black, D., Marabani, M., Sturrock, R. D., and Robins, S. P. Urinary excretion of the hydroxypyridinium cross-links of collagen in patients with rheumatoid arthritis. Ann Rheum Dis 48:641-644; 1989.
5. Blumsohn, A., Herrington, K., Hannon, R. A., Shao, P., Eyre, D. R., and Eastell, R. The effect of calcium supplementation on the circadian rhythm of bone resorption. J Clin Endocrinol Metab 79:730-735; 1994.
6. Blumsohn, A., Naylor, K. E., Assiri, A. M., and Eastell, R. Different responses of biochemical markers of bone resorption to bisphosphonate therapy in Paget disease. Clin Chem 41:1592-1598; 1995.
7. Bockman, R. S., Wilhelm, F., Siris, E., Singer, F., Chausmer, A., Bitton, R., Kotler, J., Bosco, B. J., Eyre, D. R., and Levenson, D. A multicenter trial of low dose gallium nitrate in patients with advanced Paget's disease of bone. J Clin Endocrinol Metab 80:595-602; 1995.
8. Bollen, A.-M. and Eyre, D. R. Bone resorption rates in children monitored by the urinary assay of collagen type I cross-linked peptides, Bone 15:31-34; 1994.
9. Bonde, M., Qvist, P., Fledelius, C., Riis, B. J., and Christiansen, C. Applications of an enzyme immunoassay for a new marker of bone resorption (Cross Laps): Follow-up on hormone replacement therapy and osteoporosis risk assessment. J Clin Endocrinol Metab 80:864-868; 1995.
10. Bonde, M., Qvist, P., Fledelius, C., Riis, B. J., and Christiansen, C. Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem 40:1944-1945; 1994.
11. Brenner, R. E., Vetter, U., Bollen, A. M., Mörike, M., and Eyre, D. R. Bone resorption assessed by immunoassay of urinary cross-linked collagen peptides in patients with osteogenesis imperfecta. J Bone Miner Res 9:993-997; 1994.
12. Calvo, M. S., Eyre, D. R., and Gundberg, C. M. Molecular basis and clinical application of biological markers of bone turnover. Endocrine Rev 17:333-368; 1996.
13. Colwell, A. and Eastell, R. The renal clearance of free and conjugated pyridinium cross-links of collagen. J Bone Miner Res 11:1976-1980; 1996.
14. Eyre, D. R., Dickson, I. R., and Van Ness, K. Collagen cross-linking in human bone and articular cartilage. Age-related changes in the content of mature hydroxypyridinium residues. Biochem J 252:495-500; 1988.
15. Eyre, D. R. The specificity of collagen cross-links as markers of bone and connective tissue degradation. Acta Orthop Scand 66(Suppl 266): 166-170; 1995.
16. Ezzat, S., Melmed, S., Endres, D., Eyre, D. R., and Singer, F. R. Biochemical assessment of bone formation and resorption in acromegaly. J Clin Endocrinol Metab 76:1452-1457; 1993.
17. Foged, N. T., Delaisse, J.-M., Hou, P., Lou, H., Sato, T., Winding, B., and Bonde, M. Quantitation of the collagenolytic activity of isolated osteoclasts by enzyme-linked immunosorbent assay. J Bone Miner Res 11:226-237; 1996.
18. Garnero, P., Gineyts, E., Arbault, P., Christiansen, C., and Delmas, P. D. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. J Bone Miner Res 19:641-649; 1995.
19. Garnero, P., Gineyts, E., Riou, J. P., and Delmas, P. D. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. J Clin Endocrinol Metab 79:780-785; 1994.
20. Garnero, P., Shih, W. J., Gineyts, E., Karpf, D. B., and Delmas, P. D. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 79:1693-1700; 1994.
21. Garnero, P., Sornay, R. E., and Delmas, P. D. Decreased bone turnover in oral contraceptive users. Bone 16:499-503; 1995.
22. Gertz, B. J., Shao, P., Hanson, D. A., Quan, H., Harris, S. T., Genant, H. K., Chesnut, C. H. III, and Eyre, D. R. Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine. J Bone Miner Res 9:135-142; 1994.
23. Gorai, I., Chaki, O., Nakayama, M., and Minaguchi, H. Urinary biochemical markers for bone resorption during the menstrual cycle. Calcif Tissue Int 57:100-104; 1995.
24. Hanson, D. A. and Eyre, D. R. Molecular site specificity of pyridinoline and pyrrole cross-links in type I collagen of human bone. J Biol Chem 271:26508-26516; 1996.
25. Hanson, D. A., Weis, M. A., Bollen, A.-M., Maslan, S. L., Singer, F. R., and Eyre, D. R. A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 7:1251-1258; 1992.
26. Harris, S. T., Gertz, B. J., Genant, H. K., Eyre, D. R., Survill, T. T., Ventura, J. N., DeBrock, J., Ricerca, E., and Chesnut, C. H. III, The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women. J Clin Endocrinol Metab 76:1399-1406; 1993.
27. Hattersley, G. and Chambers, T. J. Calcitonin receptors as markers for osteoclastic differentiation: Correlation between generation of bone-resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures. Endocrinology 125:1606-1612; 1989.
28. Hughes, D. E., Wright, K. R., Uy, H. L., Sasaki, A., Yoneda, R., Roodman, G. D., Mundy, G. R., and Boyce, B. F. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10:1478-1487; 1995.
29. Kitamura, K., Katoh, M., Komiyama, O., Kitagawa, H., Matsubara, F., and Kumegawa, M. Establishing a rapid bone resorption test in vitro assay using previously frozen mouse unfractionated bone cells pretreated with parathyroid hormone. Bone 14:829-834; 1993.
30. Lee, S. K., Goldring, S. R., and Lorenzo, J. A. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: A specific marker of the differentiated osteoelast that is regulated by calcitonin. Endocrinology 136: 4572-4581; 1995.
31. Liu, C., Sanghvi, R., Burnell, J. M., and Howard, G. A. Simultaneous demonstration of bone alkaline and acid phosphatase activities in plastic-embedded sections and differential inhibition of the activities. Histochemistry 86:559-565; 1987.
32. Murakami, H., Takahashi, N., Sasaki, T., Udagawa, N., Tanaka, S., Nakamura, I., Zhang, D., Barbier, A., and Suda, T. A possible mechanism of the specific action of bisphosphonates on osteoclasts: Tiludronate preferentially affects polarized osteoclasts having ruffled borders. Bone 17:137-144; 1995.
33. Pedrazzoni, M., Alfano, F. S., Gatti, C., Fantuzzi, M., Girasole, G., Campanini, C., Basini, G., and Passeri, M. Acute effects of bisphosphonates on new and traditional markers of bone resorption. Calcif Tissue Int 57:25-29; 1995.
34. Robins, S. P. An enzyme-linked immunoassay for the collagen cross-link pyridinoline. Biochem J 207:617-620; 1982.
35. Robins, S. P., Woitge, H., Hesley, R., Ju, J., Seyedin, S., and Seibel, M. J. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res 9:1643-1649; 1994.
36. Rosen, H. N., Dresner, P. R., Moses, A. C., Rosenblatt, M., Zeind, A. J., Clemens, J. D., and Greenspan, S. L. Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover. Calcif Tissue Int 54:26-29; 1994.
37. Seibel, M. J., Duncan, A., and Robins, S. P. Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases. J Rheumatol 16:964-970: 1989.
38. Seyedin, S. M., Kung, V. T., Daniloff, Y. N., Hesley, R. P., Gomez, B., Nielsen, L. A., Rosen, H. N., and Zuk, R. F. Immunoassay for urinary pyridinoline: The new marker of bone resorption. J Bone Miner Res 8:635-641; 1993.
39. Sowers, M., Eye, D., Hollis, B. W., Randolph, J. F., Shapiro, B., Jannausch, M. L., and Crutchfield, M. Biochemical markers of bone turnover in lactating and nonlactating postpartum women. J Clin Endocrinol Metab 80:2210-2216; 1995.
40. Takahashi, N., Yamana, H., Yoshiki, S., Roodman, G. D., Munday, G. R., Jones, S. J., Boyde, A., and Suda. T. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 122:1373-1382; 1988.
41. Takahashi, S., Goldring, S., Katz, M., Hilsenbeck, S., Williams, R., and Roodman, G. D. Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation. J Clin Invest 95:167-171; 1995.
42. Tokunaga, K., Taniguchi, H., Yoda, K., Shimizu, M., and Sakiyama, S. Nucleotide sequence of a full-length cDNA for mouse cytoskeletal beta-actin mRNA. Nucleic Acids Res 14:2829; 1986.
43. Wu, J.-J. and Eyre, D. R. Fine powdering exposes the mineral-protected collagen of bone to protease digestion. Calcif Tissue Int 42:243-247; 1988.
44. Yamin, M., Gorn, A. H., Flannery, M. R., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., Tapp, D. R., Krane, S. M., and Goldring, S. R. Cloning and characterization of a mouse brain calcitonin receptor complementary deoxyribonucleic acid and mapping of the calcitonin receptor gene. Endocrinology 135:2635-2643; 1994.